摘要
目的:了解糖尿病肾病(DN)致慢性肾衰竭(CRF)腹膜透析患者腹膜平衡试验(PET)特点。方法:分别测定观察组(DN致CRF组)、对照组(非DN致CRF组)腹膜透析1个月、6个月时腹透液与血液的肌酐浓度比值(D/Pcr)及超滤量,将两次结果进行对照。结果:腹透6个月时观察组D/Pcr较1个月时降低(P <0. 05),超滤量无改变;对照组以上两项指标均无变化(P>0.05)。结论:DN致CRF行腹膜透析患者应定期做PET,及时调节透析方案。
Objective： To observe the characteristics of peritoneal equilibration test（PET） in peritoneal dialysis patients with chronic renal failure by diabetic nephropathy.Methods： Creatinine D/P concentration and ultrafltration were detected at 1 month and 6 month in diabetic nephropathy group and non-diabetic nephropathy group.Results：Creatinine D/P concentration at 6 month was decreased compared with 1 month（P〈0.05）,ultrafltration did not show the same result.Creatinine D/P concentration and ultrafltration did not change in non-diabetic nephropathy group（P〉0.05）.Conclusions： PET can evaluate the threatment plans in peritoneal dialysis patients with chronic renal failure by diabetic nephropathy.
出处
《中国医药导刊》
2009年第1期26-26,23,共2页
Chinese Journal of Medicinal Guide
关键词
糖尿病肾病
慢性肾衰竭
腹膜平衡试验
Diabetic nephropathy
Chronic renal failure
Peritoneal equilibration test（PET）
